By staff writers

August 22, 2013 -- Focused-ultrasound developer InSightec has received Health Canada approval for its ExAblate system.

The third-generation version of ExAblate was approved for MR-guided focused ultrasound treatment of uterine fibroids and for pain palliation of bone metastases, according to the firm. It's now available for Canadian patients.

If you like this content, please share it with a colleague!
Copyright © 2013

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Sign in using your social networking account:
Sign in using your social networking